Products for Research Use Only
RegisterLogin

Hex

CAT: 0804-HY-131904A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-131904A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Hex is an enolase inhibitor and antimalarial agent with Ki values of 74.4 nM and 269.4 nM for ENO2 and ENO1, respectively. Hex is a NfENO and TbENO inhibitor with IC50s value of 0.14 μM and 2.1 μM, respectively. Hex has antimalarial activity against Plasmodium falciparum 3D7, Naegleria fowleri trophozoites and Plasmodium berghei ANKA strain. Hex has anti-tumor effects against intracranial tumors[1][2][3][4][5][6][7][8].
CAS Number
2004714-32-1
UNSPSC
12352005
Target
Enolase; Parasite
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/hex.html
Purity
99.96
Solubility
DMSO : 140 mg/mL (ultrasonic)
Smiles
OP(O)(C1C(N(O)CCC1)=O)=O
Molecular Formula
C5H10NO5P
Molecular Weight
195.11
References & Citations
[1]BOARD OF REGENTS, et al. Enolase inhibitors and methods of treatment there with. WO2016145113A1|[2]Lin YH, et al. An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nat Metab. 2020 Dec;2 (12) :1413-1426. |[3]Milanes JE, et al. Enolase inhibitors as therapeutic leads for Naegleria fowleri infection. PLoS Pathog. 2024 Aug 1;20 (8) :e1012412.|[4]Roster CP, et al. Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei. Pathogens. 2023 Oct 28;12 (11) :1290.|[5]Yan VC, et al. Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration. ACS Pharmacol Transl Sci. 2023 Jan 6;6 (2) :245-252. |[6]Lin Y H, et al. Eradication of ENO1-deleted glioblastoma through collateral lethality. BioRxiv, 2018: 331538.|[7]Jezewski A J, et al. Accelerated erythrocyte senescence causes dose-limiting anemia of antimalarial enolase inhibitors. Hematology. American Society of Hematology. Education Program, 2020. |[8]Jezewski AJ, et al. Targeting Host Glycolysis as a Strategy for Antimalarial Development. Front Cell Infect Microbiol. 2021 Sep 16;11:730413.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P0302-01HEX3
HY-P0294-01Hexa-His
HY-175148Hexa lipid 114
HY-P1028-01Hexa-D-arginine
HY-P0294A-01Hexa-His (TFA)
HY-W142015-01Hexa-L-Tyrosine
HY-N7698B-01Hexa-N-acetylchitohexaose
HY-P86899-01HEXB Antibody (YA6592, Rabbit)
HY-P1028A-01Hexa-D-arginine (TFA)
HY-P83979-01HEXA Antibody (YA3676, Mouse)

Alternative Products

CatalogName
CN-A038-500GMAgar, Micropropagation - Type I (Gracilaria)
M2302-20HPhaseShield™ Gel Tubes, Heavy (200x 2ml)
M2302-20LPhaseShield™ Gel Tubes, Light (200x 2ml)
BCS81BioCoupler® Glass Set (8 oz) x1
RHD55901Anti-PTGS1 Antibody (R1S27)
RHD55804Anti-TCEA1 Antibody (R1S24)
E-KAB-0614Porcine IL-2 Antibody Pair Set
RHD55803Anti-TCEA1 Antibody (R1S23)
PKSH030904Recombinant Human Purine nucleoside phosphorylase/PNP Protein (His Tag)
PKSH031350Recombinant Human Ficolin-1/Ficolin-A/FCN1 Protein (His Tag)

Popular Products